title: Downstaging Hepatocellular Carcinoma with Yttrium-90 radioembolization: resection or transplantation?
abstract: Trans Arterial Radio Embolization with Yttrium 90 in the treatment of Hepatocellular Carcinoma is becoming a new interesting tool in the treatment of patients that are considered non resectable and non transplantable. A successful downstaging could improve the number of patients that could benefit from a resection or a liver transplantation, but some points still need to be addressed.
authors.affiliation: General Surgery and Liver Transplantation, San Camillo Hospital, Circ. ne Gianicolense 87, 00151 Rome, Italy. Electronic address: gmettorre@scamilloforlanini.rm.it.
authors.forename: G M
authors.initials: GM
authors.lastname: Ettorre
authors.affiliation: General Surgery and Liver Transplantation, San Camillo Hospital, Circ. ne Gianicolense 87, 00151 Rome, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Laurenzi
authors.affiliation: General Surgery and Liver Transplantation, San Camillo Hospital, Circ. ne Gianicolense 87, 00151 Rome, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Vennarecci
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D004621:Embolization, Therapeutic / Q000379:methods*; D005260:Female; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D016031:Liver Transplantation; D015021:Yttrium Radioisotopes / Q000627:therapeutic use*
chemical_list: D015021:Yttrium Radioisotopes
keywords: Downstaging; HCC; Liver transplantation; Resection; Yttrium 90 radioembolization